BIO logo

Bio-Rad Laboratories (BIO) Long term liabilities

Annual long term liabilities:

$2.33B-$708.10M(-23.33%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BIO annual total long term liabilities is $2.33 billion, with the most recent change of -$708.10 million (-23.33%) on December 31, 2024.
  • During the last 3 years, BIO annual long term liabilities has fallen by -$1.11 billion (-32.22%).
  • BIO annual long term liabilities is now -32.22% below its all-time high of $3.43 billion, reached on December 31, 2021.

Performance

BIO Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIObalance sheet metrics

quarterly long term liabilities:

$2.34B+$13.90M(+0.60%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BIO quarterly total long term liabilities is $2.34 billion, with the most recent change of +$13.90 million (+0.60%) on March 31, 2025.
  • Over the past year, BIO quarterly long term liabilities has dropped by -$751.71 million (-24.31%).
  • BIO quarterly long term liabilities is now -41.05% below its all-time high of $3.97 billion, reached on September 30, 2021.

Performance

BIO quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIObalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

BIO Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.3%-24.3%
3 y3 years-32.2%-33.9%
5 y5 years+72.6%+53.8%

BIO Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-32.2%at low-33.9%+0.6%
5 y5-year-32.2%+72.6%-41.0%+53.8%
alltimeall time-32.2%>+9999.0%-41.0%>+9999.0%

BIO Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$2.34B(+0.6%)
Dec 2024
$2.33B(-23.3%)
$2.33B(-11.1%)
Sep 2024
-
$2.62B(+8.0%)
Jun 2024
-
$2.42B(-21.7%)
Mar 2024
-
$3.09B(+1.9%)
Dec 2023
$3.04B(-8.5%)
$3.04B(+3.9%)
Sep 2023
-
$2.92B(-0.9%)
Jun 2023
-
$2.95B(-11.0%)
Mar 2023
-
$3.31B(-0.1%)
Dec 2022
$3.32B(-3.4%)
$3.32B(+9.3%)
Sep 2022
-
$3.03B(-3.5%)
Jun 2022
-
$3.15B(-11.2%)
Mar 2022
-
$3.54B(+3.2%)
Dec 2021
$3.43B(+39.5%)
$3.43B(-13.5%)
Sep 2021
-
$3.97B(+35.3%)
Jun 2021
-
$2.94B(+8.2%)
Mar 2021
-
$2.71B(+10.3%)
Dec 2020
$2.46B(+82.5%)
$2.46B(+11.4%)
Sep 2020
-
$2.21B(+21.6%)
Jun 2020
-
$1.82B(+19.4%)
Mar 2020
-
$1.52B(+12.9%)
Dec 2019
$1.35B(+18.3%)
$1.35B(-16.4%)
Sep 2019
-
$1.61B(-6.0%)
Jun 2019
-
$1.71B(+10.3%)
Mar 2019
-
$1.55B(+36.4%)
Dec 2018
$1.14B(+35.7%)
$1.14B(-16.5%)
Sep 2018
-
$1.37B(+4.6%)
Jun 2018
-
$1.30B(+2.7%)
Mar 2018
-
$1.27B(+51.3%)
Dec 2017
$840.07M(+5.0%)
$840.07M(-3.5%)
Sep 2017
-
$870.83M(-0.7%)
Jun 2017
-
$877.35M(+4.7%)
Mar 2017
-
$837.80M(+4.7%)
Dec 2016
$800.02M(+2.8%)
$800.02M(-8.5%)
Sep 2016
-
$874.32M(+2.9%)
Jun 2016
-
$849.67M(+5.1%)
Mar 2016
-
$808.08M(+3.9%)
Dec 2015
$777.86M(+9.7%)
$777.86M(-2.9%)
Sep 2015
-
$801.43M(+5.1%)
Jun 2015
-
$762.55M(+7.3%)
Mar 2015
-
$710.80M(+0.2%)
Dec 2014
$709.36M(-0.7%)
$709.36M(+0.5%)
Sep 2014
-
$705.51M(-4.3%)
Jun 2014
-
$737.56M(+1.4%)
Mar 2014
-
$727.52M(+1.8%)
Dec 2013
$714.60M(-25.2%)
$714.60M(+3.1%)
Sep 2013
-
$693.28M(-29.3%)
Jun 2013
-
$980.63M(+0.2%)
Mar 2013
-
$978.85M(+2.4%)
Dec 2012
$955.56M(+7.0%)
$955.56M(+2.3%)
Sep 2012
-
$933.87M(+3.9%)
Jun 2012
-
$899.22M(-0.5%)
Mar 2012
-
$903.75M(+1.2%)
Dec 2011
$893.31M(+4.4%)
$893.31M(+3.8%)
Sep 2011
-
$860.82M(-1.7%)
Jun 2011
-
$875.49M(+0.9%)
Mar 2011
-
$867.69M(+1.4%)
Dec 2010
$855.62M(+2.3%)
$855.62M(+1.5%)
Sep 2010
-
$843.38M(+1.0%)
Jun 2010
-
$834.90M(-1.5%)
Mar 2010
-
$847.78M(+1.3%)
Dec 2009
$836.67M(+52.5%)
$836.67M(+0.2%)
Sep 2009
-
$834.84M(+0.2%)
Jun 2009
-
$833.21M(+54.0%)
Mar 2009
-
$541.13M(-1.4%)
Dec 2008
$548.59M(-6.3%)
$548.59M(+1.0%)
Sep 2008
-
$543.31M(-0.1%)
Jun 2008
-
$544.10M(-1.7%)
Mar 2008
-
$553.33M(-5.5%)
Dec 2007
$585.74M(+28.1%)
$585.74M(+22.1%)
Sep 2007
-
$479.68M(+0.8%)
Jun 2007
-
$476.10M(+0.4%)
Mar 2007
-
$474.29M(+3.8%)
Dec 2006
$457.10M
$457.10M(-0.1%)
DateAnnualQuarterly
Sep 2006
-
$457.58M(+0.1%)
Jun 2006
-
$456.90M(+0.9%)
Mar 2006
-
$453.00M(+0.8%)
Dec 2005
$449.37M(-2.2%)
$449.37M(-6.0%)
Sep 2005
-
$477.80M(+1.0%)
Jun 2005
-
$473.08M(-0.6%)
Mar 2005
-
$476.15M(+3.7%)
Dec 2004
$459.36M(+78.4%)
$459.36M(+72.6%)
Sep 2004
-
$266.16M(-0.4%)
Jun 2004
-
$267.10M(+3.5%)
Mar 2004
-
$258.05M(+0.2%)
Dec 2003
$257.54M(+122.8%)
$257.54M(+10.1%)
Sep 2003
-
$234.02M(+117.4%)
Jun 2003
-
$107.66M(-0.5%)
Mar 2003
-
$108.20M(-6.4%)
Dec 2002
$115.61M(-42.5%)
$115.61M(-22.9%)
Sep 2002
-
$149.91M(-6.6%)
Jun 2002
-
$160.51M(-14.3%)
Mar 2002
-
$187.37M(-6.8%)
Dec 2001
$201.04M(-5.3%)
$201.04M(+1.8%)
Sep 2001
-
$197.49M(-2.8%)
Jun 2001
-
$203.10M(-4.2%)
Mar 2001
-
$212.07M(-0.1%)
Dec 2000
$212.35M(-13.8%)
$212.35M(-4.2%)
Sep 2000
-
$221.64M(-11.9%)
Jun 2000
-
$251.46M(-5.6%)
Mar 2000
-
$266.41M(+8.2%)
Dec 1999
$246.30M(+341.4%)
$246.30M(+394.6%)
Sep 1999
-
$49.80M(-13.1%)
Jun 1999
-
$57.30M(-2.6%)
Mar 1999
-
$58.80M(+5.4%)
Dec 1998
$55.80M(+2.6%)
$55.80M(+1.1%)
Sep 1998
-
$55.20M(-15.1%)
Jun 1998
-
$65.00M(+2.0%)
Mar 1998
-
$63.70M(+17.1%)
Dec 1997
$54.40M(+143.9%)
$54.40M(+162.8%)
Sep 1997
-
$20.70M(+14.4%)
Jun 1997
-
$18.10M(-11.3%)
Mar 1997
-
$20.40M(-8.5%)
Dec 1996
$22.30M(-41.6%)
$22.30M(-35.7%)
Sep 1996
-
$34.70M(0.0%)
Jun 1996
-
$34.70M(-10.3%)
Mar 1996
-
$38.70M(+1.3%)
Dec 1995
$38.20M(-13.2%)
$38.20M(-11.8%)
Sep 1995
-
$43.30M(+6.9%)
Jun 1995
-
$40.50M(-4.5%)
Mar 1995
-
$42.40M(-3.6%)
Dec 1994
$44.00M(-29.3%)
$44.00M(-3.3%)
Sep 1994
-
$45.50M(-11.8%)
Jun 1994
-
$51.60M(-12.2%)
Mar 1994
-
$58.80M(-5.5%)
Dec 1993
$62.20M(-7.4%)
$62.20M(+45.7%)
Sep 1993
-
$42.70M(-5.1%)
Jun 1993
-
$45.00M(-38.2%)
Mar 1993
-
$72.80M(+8.3%)
Dec 1992
$67.20M(-4.3%)
$67.20M(+10.2%)
Sep 1992
-
$61.00M(-3.9%)
Jun 1992
-
$63.50M(-9.5%)
Mar 1992
-
$70.20M(0.0%)
Dec 1991
$70.20M(+47.8%)
$70.20M(+12.9%)
Sep 1991
-
$62.20M(+24.9%)
Jun 1991
-
$49.80M(+1.6%)
Mar 1991
-
$49.00M(+3.2%)
Dec 1990
$47.50M(+15.3%)
$47.50M(-0.2%)
Sep 1990
-
$47.60M(+13.1%)
Jun 1990
-
$42.10M(-0.5%)
Mar 1990
-
$42.30M(+2.7%)
Dec 1989
$41.20M(-2.8%)
$41.20M(-1.9%)
Sep 1989
-
$42.00M(-11.0%)
Jun 1989
-
$47.20M(+11.3%)
Dec 1988
$42.40M(+16.2%)
$42.40M(+16.2%)
Dec 1987
$36.50M(+42.6%)
$36.50M(+42.6%)
Dec 1986
$25.60M(+44.6%)
$25.60M(+44.6%)
Dec 1985
$17.70M(-37.0%)
$17.70M(-37.0%)
Dec 1984
$28.10M
$28.10M

FAQ

  • What is Bio-Rad Laboratories annual total long term liabilities?
  • What is the all time high annual long term liabilities for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories annual long term liabilities year-on-year change?
  • What is Bio-Rad Laboratories quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Bio-Rad Laboratories?
  • What is Bio-Rad Laboratories quarterly long term liabilities year-on-year change?

What is Bio-Rad Laboratories annual total long term liabilities?

The current annual long term liabilities of BIO is $2.33B

What is the all time high annual long term liabilities for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high annual total long term liabilities is $3.43B

What is Bio-Rad Laboratories annual long term liabilities year-on-year change?

Over the past year, BIO annual total long term liabilities has changed by -$708.10M (-23.33%)

What is Bio-Rad Laboratories quarterly total long term liabilities?

The current quarterly long term liabilities of BIO is $2.34B

What is the all time high quarterly long term liabilities for Bio-Rad Laboratories?

Bio-Rad Laboratories all-time high quarterly total long term liabilities is $3.97B

What is Bio-Rad Laboratories quarterly long term liabilities year-on-year change?

Over the past year, BIO quarterly total long term liabilities has changed by -$751.71M (-24.31%)
On this page